<PAGE>
Page 1 of 5
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
SIBIA Neurosciences, Inc.
- ------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
- ------------------------------------------------------------------------------
(Title of Class of Securities)
8257321
- ------------------------------------------------------------------------------
(CUSIP Number)
-----------
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section of the Exchange Act but shall be subject to all
other provisions of the Exchange Act.
<PAGE>
Page 2 of 5
SCHEDULE 13G
- -------------------------
CUSIP No. 8257321
- -------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BRISTOL-MYERS SQUIBB COMPANY
I.R.S. Employer Identification Number 22-079-0350
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 658,000
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 0
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 658,000
PERSON 8 SHARED DISPOSITIVE POWER
0
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
658,000
- ------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES [_]
------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT ON ROW (9)
7.2%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
<PAGE>
Page 3 of 5
- -------------------------
CUSIP NO. 8257321
- -------------------------
Item 1(a). Name of Issuer:
SIBIA Neurosciences, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
505 Coast Boulevard South, Suite 300, La Jolla, CA 92037-4641
Item 2(a). Name of Person Filing:
Bristol-Myers Squibb Company
Item 2(b). Address of Principal Business Office or, if None, Residence:
345 Park Avenue, New York, NY 10154
Item 2(c). Citizenship:
Delaware
Item 2(d). Title of Class of Securities:
Common Stock, $.001 par value per share
Item 2(e). CUSIP Number:
8257321
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2
(b), check whether the person filing is a:
(a) [_] Broker or dealer registered under Section 15 of the
Act,
(b) [_] Bank as defined in Section 3(a)(6) of the Act,
(c) [_] Insurance Company as defined in Section 3(a)(19) of
the Act,
(d) [_] Investment Company registered under Section 8 of the
Investment Company Act,
(e) [_] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940,
(f) [_] Employee Benefit Plan, Pension Fund which is subject
to the provisions of the Employee Retirement Income
Security act of 1974 or Endowment Fund;
see 13d-1(b)(1)(ii)(F),
(g) [_] Parent Holding Company, in accordance with
Rule 13d-1(b)(i)(G); see Item 7,
(h) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
<PAGE>
Page 4 of 5
- -------------------------
CUSIP NO. 8257321
- -------------------------
Item 4. Ownership.
If the percent of the class owned, as of December 31 of the year
covered by the statement, or as of the last day of any month described in
Rule 13d-1 (b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a right
to acquire.
(a) Amount beneficially owned:
658,000
-----------------------------------------------------------
(b) Percent of class:
7.2%
-----------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote 658,000 ,
-------------------
(ii) Shared power to vote or to direct the vote 0 ,
-----------------
(iii) Sole power to dispose or to direct the disposition of
658,000 ,
-----------------
(iv) Shared power to dispose or to direct the disposition of 0 .
----
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not Applicable.
<PAGE>
Page 5 of 5
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such securities
and were not acquired in connection with or as a participant in any
transaction having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement is true, complete and
correct.
Dated: January 30, 1997 BRISTOL-MYERS SQUIBB COMPANY
By:/s/____________________________
Alice C. Brennan
Vice President and Secretary
